Kenya in a drive to attain WHO medicine production level in the next five months

Audio By Vocalize

Kenya is ramping up efforts to attain the World Health Organization's (WHO) Maturity Level 3 (ML3) status in pharmaceutical regulation by December this year.

This is a milestone expected to strengthen oversight of medical products, boost local manufacturing, and improve access to safe and effective medicines.

The Ministry of Health, through the Pharmacy and Poisons Board (PPB), is leading reforms aimed at elevating the country's regulatory system from its current Maturity Level 2 (ML2) ranking to the internationally recognised ML3 standard.

Achieving ML3 status would place Kenya among a select group of African nations with stable and well-functioning regulatory systems capable of ensuring the quality, safety and efficacy of medicines and other health products.